ask="0.5400"
ask_size="400"
average_daily_volume="515125"
bid="0.5300"
bid_size="1000"
book_value="0.8130"
change="+0.0251"
change_from_200_day_moving_average="0.0281"
change_from_50_day_moving_average="-0.0286"
change_from_52_week_high="-0.8848"
change_From_52_week_low="0.2041"
change_in_percent="+4.9216%"
close="0.5351"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.5350"
ebitda="-17.93M"
eps_estimate_current_year="-0.7800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.5700"
ex_dividend_date="N/A"
float_shares="29628000"
high="0.5450"
high_52_weeks="1.4199"
last_trade_date="3/9/2017"
last_trade_price="0.5351"
last_trade_size="100"
last_trade_time="3:59pm"
low="0.5001"
low_52_weeks="0.3310"
market_capitalization="16.06M"
moving_average_200_day="0.5070"
moving_average_50_day="0.5637"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.9000"
open="0.5006"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+5.5364%"
percent_change_from_50_day_moving_average="-5.0760%"
percent_change_from_52_week_high="-62.3142%"
percent_change_from_52_week_low="+61.6616%"
previous_close="0.5100"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.6273"
price_per_sales="1.3810"
revenue="11.09M"
shares_outstanding="30020000"
short_ratio="4.0600"
stock_exchange="NCM"
symbol="OGXI"
volume="456392"
weeks_range_52="0.3310 - 1.4199"
